ICM
INCY icon

Invenomic Capital Management’s Incyte INCY Stock Holding History

Invenomic Capital Management’s Portfolio INCY Stock Details INCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-76,771
Closed -$5.3M – 182
2024
Q4 		$5.3M Sell
76,771
-11,981
-13% -$854K 0.25% 110
2024
Q3 		$5.87M Sell
88,752
-17,485
-16% -$1.11M 0.32% 90
2024
Q2 		$6.44M Buy
+106,237
New +$6.02M 0.31% 92

Other funds holding INCY

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Invenomic Capital Management's INCY Position: Q1 2025 in Review

Invenomic Capital Management sold out of Incyte (INCY) in Q1 2025, closing a stake of 76,771 shares — an estimated $5.3M sold.

Invenomic Capital Management first reported a position in INCY in Q2 2024 and held it in 3 quarters. The position peaked at $6.44M in Q2 2024. 629 funds tracked by Wall St. Rank hold INCY as of Q1 2025.

  • Invenomic Capital Management reported no remaining Incyte position as of Q1 2025 after selling out during the quarter.
  • Invenomic Capital Management sold 76,771 Incyte shares in Q1 2025, an estimated $5.3M.
  • Invenomic Capital Management first reported a position in Incyte in Q2 2024 and held it in 3 quarters.
  • Invenomic Capital Management's Incyte position peaked at $6.44M in Q2 2024.
  • 629 funds tracked by Wall St. Rank held Incyte as of Q1 2025.

Based on Invenomic Capital Management's 13F filing for Q1 2025, filed 15 May 2025.